Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Oct 16, 2025
Reporting period
Not applicable
Filed with the SEC
Oct 20, 2025
CEOOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001773751-25-000342
Filed / recorded
Oct 20, 2025, 8:42 PM UTC
Added to OQRO
Oct 6, 2026, 7:59 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Hims & Hers Health, Inc.
Issuer CIK
1773751
Ticker
HIMS
Reporting person
Andrew Dudum
Relationship
Director, Officer, 10% owner
Officer title
Chief Executive Officer
Security
Stock Option (right to buy)
Table
Derivative (Table II)
Transaction date
Oct 16, 2025
Transaction code
M
Shares / units
17,001
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
17,005
Ownership form
Direct
Amendment
No
Footnotes from the filing
The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.
Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.